Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

NCT: NCT05324397 · COMPLETED

NCT IDNCT05324397
StatusCOMPLETED
Start Date2022-03-14
Completion2023-10-04
SponsorNeurent Medical (INDUSTRY)
First posted
Last updated

Brief Summary

The CLARITY Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.

Frequently Asked Questions

What is Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)?

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY) is a clinical trial registered under NCT05324397. Current status: COMPLETED.

What is the status of NCT05324397?

The current status of NCT05324397 (Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)) is: COMPLETED.

When did Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY) start?

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY) started on 2022-03-14.

Related Devices

K212666Neuromark SystemNeurent Medical K222032NEUROMARK SystemNeurent Medical K250048NEUROMARK System (NMK00301)Neurent Medical , Ltd. K261833NEUROMARK System (NMK00301)Neurent Medical , Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑